Sval2 inhibitors are a class of chemical compounds designed to specifically target and inhibit the function of the Sval2 protein, a molecular entity believed to be involved in key cellular processes such as structural integrity, signaling, or molecular transport. Sval2, like other proteins in its class, may play a role in facilitating interactions between cellular components or in mediating important biochemical pathways. The inhibition of Sval2 can disrupt its functional capacity, thereby altering the intracellular processes it influences. Although the precise biological function of Sval2 may still be under investigation, it is likely involved in maintaining critical cellular functions, either by directly interacting with other proteins or by modulating pathways that contribute to cellular homeostasis.
Inhibitors of Sval2 function through a variety of mechanisms, depending on the nature of the inhibitor. Some compounds may act by binding directly to the active site of Sval2, preventing its interaction with other molecular partners. Others may cause conformational changes in the protein structure, reducing its ability to participate in cellular processes effectively. These inhibitors can have wide-ranging effects on cellular behavior, potentially altering signal transduction, cellular architecture, or other vital functions depending on the role of Sval2 in the cell. By studying Sval2 inhibitors, researchers gain insights into the molecular mechanics that underlie protein interactions and cellular regulation. This deepens our understanding of how individual proteins contribute to broader biological systems and highlights the importance of targeting specific molecular components to uncover their roles in complex intracellular environments.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D inhibits RNA polymerase activity, potentially leading to decreased transcription of seminal vesicle antigen-like 2. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin inhibits PI3K, a kinase involved in cellular signaling, which may impact pathways regulating seminal vesicle antigen-like 2 expression. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Tunicamycin inhibits protein glycosylation, potentially affecting protein folding and secretion, thus influencing seminal vesicle antigen-like 2 expression. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine inhibits protein kinases, which may disrupt signaling pathways involved in regulating seminal vesicle antigen-like 2 expression. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Triptolide exhibits inhibitory effects on transcriptional activity, which may lead to decreased expression of seminal vesicle antigen-like 2. | ||||||
Piceatannol | 10083-24-6 | sc-200610 sc-200610A sc-200610B | 1 mg 5 mg 25 mg | $50.00 $70.00 $195.00 | 11 | |
Piceatannol inhibits tyrosine kinases, potentially disrupting signaling pathways that regulate seminal vesicle antigen-like 2 expression. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A23187 is a calcium ionophore that can modulate signaling pathways, potentially influencing seminal vesicle antigen-like 2 expression. | ||||||
SB 218078 | 135897-06-2 | sc-203692 | 1 mg | $133.00 | 1 | |
SB-218078 inhibits GSK-3β, a kinase involved in cellular signaling, which may impact pathways regulating seminal vesicle antigen-like 2 expression. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $96.00 $250.00 $750.00 $1428.00 | 280 | |
Bafilomycin A1 inhibits vacuolar ATPase, potentially affecting cellular processes that regulate seminal vesicle antigen-like 2 expression. | ||||||
GSK1904529A | 1089283-49-7 | sc-507398 | 10 mg | $321.00 | ||
GSK1904529A inhibits PI3K and mTOR, key kinases in cellular signaling pathways that regulate seminal vesicle antigen-like 2 expression. |